Table 2.
Univariate | Multivariablea | ||||||
---|---|---|---|---|---|---|---|
Cohort | Gene symbol | Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value |
TTC | ALG5 (218203_at) | 2.42 | 1.57–3.75 | p < 0.0001 | 1.90 | 1.10–3.29 | 0.0209 |
GPR107 (211979_at) | 0.337 | 0.199–0.574 | p < 0.0001 | 0.361 | 0.190–0.686 | 0.00185 | |
NUP188 (212691_at) | 0.340 | 0.199–0.581 | p < 0.0001 | 0.260 | 0.126–0.536 | 0.000263 | |
HH | ALG5 | 1.60 | 1.03–2.49 | 0.0368 | 1.62 | 1.06–2.49 | 0.0255 |
GPR107 | 0.948 | 0.343–2.63 | 0.92 | 0.801 | 0.273–2.36 | 0.687 | |
NUP188 | 0.984 | 0.671–1.44 | 0.935 | 0.953 | 0.647–1.41 | 0.810 | |
UVA-55 | ALG5 (218203_at) | 3.08 | 1.07–8.81 | 0.0365 | 3.36 | 1.05–10.7 | 0.0406 |
GPR107 (211979_at) | 0.451 | 0.117–1.75 | 0.249 | 0.447 | 0.113–1.77 | 0.252 | |
NUP188 (212691_at) | 0.398 | 0.11–1.44 | 0.160 | 0.289 | 0.0616–1.36 | 0.116 |
Bold values indicate statistical significance p < 0.05.
aMultivariable analysis adjusted for stage and age. Gene expression, stage and age as continuous variables.